1. Home
  2. RVNC vs CFSB Comparison

RVNC vs CFSB Comparison

Compare RVNC & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • CFSB
  • Stock Information
  • Founded
  • RVNC 1999
  • CFSB 1889
  • Country
  • RVNC United States
  • CFSB United States
  • Employees
  • RVNC N/A
  • CFSB N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • CFSB Major Banks
  • Sector
  • RVNC Health Care
  • CFSB Finance
  • Exchange
  • RVNC Nasdaq
  • CFSB Nasdaq
  • Market Cap
  • RVNC 546.4M
  • CFSB 44.9M
  • IPO Year
  • RVNC 2014
  • CFSB N/A
  • Fundamental
  • Price
  • RVNC $5.28
  • CFSB $6.77
  • Analyst Decision
  • RVNC Buy
  • CFSB
  • Analyst Count
  • RVNC 10
  • CFSB 0
  • Target Price
  • RVNC $10.86
  • CFSB N/A
  • AVG Volume (30 Days)
  • RVNC 3.6M
  • CFSB 3.0K
  • Earning Date
  • RVNC 11-06-2024
  • CFSB 11-12-2024
  • Dividend Yield
  • RVNC N/A
  • CFSB N/A
  • EPS Growth
  • RVNC N/A
  • CFSB N/A
  • EPS
  • RVNC N/A
  • CFSB 0.01
  • Revenue
  • RVNC $251,178,000.00
  • CFSB $7,692,000.00
  • Revenue This Year
  • RVNC $20.36
  • CFSB N/A
  • Revenue Next Year
  • RVNC $31.66
  • CFSB N/A
  • P/E Ratio
  • RVNC N/A
  • CFSB $1,311.56
  • Revenue Growth
  • RVNC 40.23
  • CFSB N/A
  • 52 Week Low
  • RVNC $2.30
  • CFSB $5.85
  • 52 Week High
  • RVNC $9.90
  • CFSB $7.95
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 39.70
  • CFSB 52.60
  • Support Level
  • RVNC $5.13
  • CFSB $6.69
  • Resistance Level
  • RVNC $5.41
  • CFSB $6.89
  • Average True Range (ATR)
  • RVNC 0.20
  • CFSB 0.09
  • MACD
  • RVNC -0.02
  • CFSB 0.00
  • Stochastic Oscillator
  • RVNC 42.19
  • CFSB 65.41

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About CFSB CFSB Bancorp Inc.

CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.

Share on Social Networks: